Cardiovascular Disease

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

By

Certain factors have been associated with accelerated atherosclerosis in spondyloarthritis without overt cardiovascular disease.

Cardiovascular Event Risk Not Increased With Liraglutide

Cardiovascular Event Risk Not Increased With Liraglutide

Liraglutide treatment for weight management is not associated with increased risk of cardiovascular event.

Cardiovascular Risk Examined in HIV-Positive Premenopausal Women

Cardiovascular Risk Examined in HIV-Positive Premenopausal Women

By

Traditional risk factors for cardiovascular disease are linked to a higher risk of heart disease in HIV-positive premenopausal women than HIV itself.

Management of Cardiovascular Risk Factors Still Key for People With RA

Management of Cardiovascular Risk Factors Still Key for People With RA

By

Knowledge regarding the impact of various risk factors for cardiovascular disease (CVD) events is essential for the establishment of individualized risk evaluation and prevention.

Hypertension During Pregnancy Increases Risk for Future CVD

Hypertension During Pregnancy Increases Risk for Future CVD

By

Women who experience gestational hypertension are at a greater risk for future hypertension and ischemic heart disease compared with women who have preeclampsia.

Cardiovascular Risk May Be Reduced With Meditation

Cardiovascular Risk May Be Reduced With Meditation

Meditation may be considered as an adjunct to guideline-directed cardiovascular risk reduction.

Cardiovascular Risks Increase After Discontinuing Low-Dose Aspirin

Cardiovascular Risks Increase After Discontinuing Low-Dose Aspirin

There is more than a 30% increased risk of cardiovascular events following discontinuation of low-dose aspirin in long-term users.

Cardiovascular Disease Risks With Fertility Treatment: What We Know

Cardiovascular Disease Risks With Fertility Treatment: What We Know

By

The underlying cause of infertility is a major variable in confirming the link between fertility treatment and cardiovascular disease.

Insulin Dose Not Tied to Cardiovascular Outcomes

Insulin Dose Not Tied to Cardiovascular Outcomes

Cardiovascular outcomes in patients with diabetes are not explained by insulin resistance.

Worldwide CVD and Mortality Risk Lowered With More Physical Activity

Worldwide CVD and Mortality Risk Lowered With More Physical Activity

Higher recreational and non-recreational physical activity is associated with a lower risk of mortality and cardiovascular disease events.

Hypertensive Disorders in Pregnancy Associated With Increased Risk for CVD Postpartum

Hypertensive Disorders in Pregnancy Associated With Increased Risk for CVD Postpartum

By

Women with hypertensive disorders in pregnancy are at increased risk of developing cardiovascular disease and hypertension postpartum.

Is Statin Use Associated With a Reduction of CV Events, Mortality in Older Men?

Is Statin Use Associated With a Reduction of CV Events, Mortality in Older Men?

Statin use is associated with a significantly lower risk of mortality in older male physicians, and a non-significant lower risk of cardiovascular disease events.

Cardiovascular Risk in Type 2 Diabetes Not Increased With Exenatide

Cardiovascular Risk in Type 2 Diabetes Not Increased With Exenatide

The risk of major cardiovascular events is similar for those receiving exenatide or placebo for patients with type 2 diabetes.

Metabolically Healthy Obese Individuals Still at Higher Risk for CV Events

Metabolically Healthy Obese Individuals Still at Higher Risk for CV Events

Metabolically healthy obese individuals have increased risk of coronary heart disease, cerebrovascular disease than those of normal weight.

High Levels of Stem Cell Factor Linked to Reduced CV Events

High Levels of Stem Cell Factor Linked to Reduced CV Events

High levels of stem cell factor are associated with reduced risk of mortality and cardiovascular events.

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

Hypercoagulability in Sleep Apnea Can Increase Risk for CV Complications

By

People with obstructive sleep apnea could have a higher risk for hypercoagulability.

Cardiovascular Risk Factors in Cross-Sex Hormone Therapy: Expert Opinion

Cardiovascular Risk Factors in Cross-Sex Hormone Therapy: Expert Opinion

By

In a meta-analysis of cross-sex hormone therapy use in transgender individuals, researchers found that transgender women may have a greater risk for CVD mortality vs cisgender women in the general population.

Cardiovascular Event Risk Better Predicted by ApoB vs LDL Cholesterol Level

Cardiovascular Event Risk Better Predicted by ApoB vs LDL Cholesterol Level

Clinical benefit of reduced low-density lipoprotein cholesterol (LDL-C) levels may depend on the corresponding reduction in apolipoprotein B (apoB)-containing lipoprotein particles.

Anti-Tumor Necrosis Factor Drug Improves CV Health in Psoriatic Arthritis

Anti-Tumor Necrosis Factor Drug Improves CV Health in Psoriatic Arthritis

By

Cardiovascular health in psoriatic arthritis improves with anti-tumor necrosis factor drug etanercept.

Greater Risk for Heart Failure, Arrhythmia With Androgen-Deprivation Therapy

Greater Risk for Heart Failure, Arrhythmia With Androgen-Deprivation Therapy

Use of androgen-deprivation therapy may increase the risk of certain cardiovascular conditions in men with prostate cancer.

Cardiovascular Disease Risk and Dietary Fat Intake: Update and Expert Roundtable

Cardiovascular Disease Risk and Dietary Fat Intake: Update and Expert Roundtable

By

The American Heart Association has shifted its dietary recommendations from replacing total fat with carbohydrates to replacing saturated and trans fats with unsaturated fat.

CVD in Rheumatoid Arthritis: How Can We Improve Diagnosis?

CVD in Rheumatoid Arthritis: How Can We Improve Diagnosis?

By

Patients with rheumatoid arthritis have a significantly higher risk for cardiovascular disease, increasing their risk for morbidity and mortality.

Examining Cardiovascular Disease Risk Associated With Hepatitis C Infection

Examining Cardiovascular Disease Risk Associated With Hepatitis C Infection

By

Hepatitis C virus infection is a common cause of chronic liver disease worldwide and is associated with greater mortality.

Hypertension-Related Mortality Increased With Marijuana Use

Hypertension-Related Mortality Increased With Marijuana Use

Marijuana increases by 3-fold the risk for hypertension-related mortality.

Cardiovascular Disease Risk Increases After Hospitalization for Sepsis, Pneumonia

Cardiovascular Disease Risk Increases After Hospitalization for Sepsis, Pneumonia

There is an increased risk of cardiovascular disease for patients diagnosed with sepsis or pneumonia that persists for at least 5 years after infection.

Effect of Vitamin B Supplementation on Fracture Risk in Women at High Risk for CVD

Effect of Vitamin B Supplementation on Fracture Risk in Women at High Risk for CVD

B vitamin and folic acid supplementation does not affect fracture risk or bone turnover in women with preexisting CVD.

Increases in NT-proBNP and hsTnI Delayed in Type 2 Diabetes With Canagliflozin

Increases in NT-proBNP and hsTnI Delayed in Type 2 Diabetes With Canagliflozin

Canagliflozin delayed the rise in several cardiac biomarkers for over 2 years in older type 2 diabetes patients patients.

USPSTF Updated Guidelines on Behavioral Counseling for CVD Prevention, Plus Expert Interview

USPSTF Updated Guidelines on Behavioral Counseling for CVD Prevention, Plus Expert Interview

By

An overview of new USPSTF recommendations for behavioral lifestyle counseling for the prevention of cardiovascular disease plus an expert interview.

CVD Risk Factors May Be Altered in Transgender Adults Receiving Hormone Therapy

CVD Risk Factors May Be Altered in Transgender Adults Receiving Hormone Therapy

Transgender adults receiving cross-sex hormone therapy may have altered risk factors for cardiovascular disease.

CVD Risk in Diabetes Predicted by Visceral to Subcutaneous Fat Area Ratio

CVD Risk in Diabetes Predicted by Visceral to Subcutaneous Fat Area Ratio

In patients with increasing visceral to subcutaneous fat area ratio quartiles, there were more first or recurring cardiovascular disease.

Sign Up for Free e-Newsletters